Ledger.Open graph →
SEC Form D · filed August 14, 2018

Paragon Biosciences Emalex Capital, Inc

Offering
$6.9M
Sold
$6.9M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
NORTHBROOK, IL
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (8)

Sophie Pibouin · COLUMBUS, OHExec · DirectorRoger Kahn · COLUMBUS, OHDirectorTom Marrel · Scottsdale, AZExecNathan H. Pearl · San Francisco, CADirectorRussell Middleton · San Francisco, CADirectorTanner Beckstrand · Bluffdale, UTDirectorVishal Makhijani · San Francisco, CAExecGeorge A. Kahle, Iii · Vero Beach, FLExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗